Financial Data & Stock Exchanges. Scored on the same transparent model behind the daily rankings.
★
CBOE
Cboe Global Markets, Inc. · Financial Data & Stock Exchanges
58.1Financial strength
$304.16Oct 9 close$31.8B
1Y Target$320.47Analyst consensus · 15 analysts
5Y Target$469.20Compound horizon
10Y Target$696.02Long-dated conviction
FCF$1.9bTTM · 06/26C+
FCF $1.9b — respectable but not differentiating · Trailing twelve months to 06/26 (operating cash flow − capex).
Rev+15.1%FY YoYB+
Revenue +15.1% — above sector median, healthy trajectory · Computed from the last two annual revenue figures (FY YoY).
D/E0.28B+
D/E 0.28 — below the Financial Services debt median (≈40th pctile)
P/E23.7xC
P/E 23.7 — expensive vs Financial Services peers (≈90th pctile)
PEG2.60C
PEG 2.60 — expensive relative to growth rate
Targets: 1-year is analyst consensus where covered, 5- and 10-year are model estimates; the DCF is a cross-check, not a target. Methodology
Financial strength · 58.1 / 100
Profitability96.3
Value (P/B)12.0
Income44.6
A peer-relative read for financials on profitability (ROE), valuation, and covered income — the quality-growth (FCF/ROIC) screen doesn't apply to balance-sheet businesses. Not comparable to the 0–100 quality-growth score shown on other stocks.
Entry · Margin of safety
52-week rangeMid-range
18% off the 12-month high
Model-generatedFrom reported fundamentals, checked against the figures above · Editorial standards
Why now
Financial Data & Stock Exchanges · market cap $31.8b. 18% off the 52-week high of $371.18. Revenue growing +15%, comfortably above the S&P median. 15 sell-side analysts rate this a Hold with a mean 1-yr target of $320.47 (implying +5% upside).
Moat
Net margin 27% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 26% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 139% of net income, helped by cash released from working capital ($446m) that doesn't repeat every year.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Horizon
1-3 yr $320.47 (15-analyst consensus) — fundamentals + valuation re-rating. 5 yr $469.20 at ~9% CAGR — compounding case rests on the competitive position widening. 10 yr $696.02 if current growth sustains into durable earnings power.
Score history · CBOE
Not enough history yet — the model records CBOE's score after each daily run, and the chart appears once a few days have accumulated.
CBOE at a glance
Same audited fundamentals as the score, unless a card says otherwise.
Analyst estimate revisions
30-day change
-0.3%
90-day change
+2.2%
Forward EPS estimate
$15.19
Over the last 90 days, what analysts expect CBOE to earn is drifting higher (+2.2%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →
Position sizing · CBOE
$
%
%
Shares to buy
6
Position size
$1,825
3.6% of portfolio
Stop price
$228.12
25% below $304.16
$ at risk if stopped
$456.24
budget $500.00 · 1% of portfolio
Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.
Cboe Global Markets, Inc. (CBOE): score, valuation & FAQ
Cboe Global Markets, Inc. (CBOE) is a Financial Data & Stock Exchanges company. As a bank, insurer or REIT it runs on a different financial model from the rest of the market, so Bull Rankings grades it on a sector-appropriate card — price-to-book, dividend yield, payout ratio and cash-flow coverage — rather than the 0–100 quality-growth score used elsewhere. The read below is a transparent screen, not a buy recommendation.
Its strongest graded signals are Rev (B+) and D/E (B+).
Is CBOE a good stock to buy?
Bull Rankings grades CBOE on a sector-appropriate card — price-to-book, dividend yield, payout and cash-flow coverage — rather than a single quality-growth score. That is driven by Rev (B+) and D/E (B+). A score is a quantitative screen of Cboe Global Markets, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
How does Bull Rankings grade CBOE?
As a bank, insurer or REIT, CBOE isn't given a quality-growth score — signals like free cash flow, debt-to-equity and P/E don't translate cleanly to a balance-sheet business. Instead it's graded on a sector-appropriate card: price-to-book, dividend yield, payout ratio and operating-cash-flow coverage, where it rates strongest on Rev (B+) and D/E (B+).
Is CBOE overvalued or undervalued?
We don't publish a discounted-cash-flow value for CBOE, and not because the business is unprofitable. For a lender, insurer or property trust, "free cash flow" measures balance-sheet growth rather than owner earnings — loan originations and repayments run through operating cash flow — so discounting it would produce a confident-looking number with nothing behind it. CBOE is judged on book value, return on equity and income cover instead, which is what the financial-strength card shows.
What are the main risks of investing in CBOE?
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.